BBS7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.180000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.826200E-01
Normal-vs-Stage2
6.626600E-01
Normal-vs-Stage3
6.215000E-01
Normal-vs-Stage4
1.544020E-01
Stage1-vs-Stage2
3.879000E-01
Stage1-vs-Stage3
1.671410E-01
Stage1-vs-Stage4
2.999800E-01
Stage2-vs-Stage3
2.927800E-01
Stage2-vs-Stage4
2.216300E-02
Stage3-vs-Stage4
6.329700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.220200E-01
Normal-vs-AfricanAmerican
4.443400E-01
Normal-vs-Asian
9.910000E-01
Caucasian-vs-AfricanAmerican
6.089800E-01
Caucasian-vs-Asian
3.705200E-01
AfricanAmerican-vs-Asian
3.338000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.251000E-01
Normal-vs-Female
5.018000E-01
Male-vs-Female
1.915820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.316400E-01
Normal-vs-Age(41-60Yrs)
3.108200E-01
Normal-vs-Age(61-80Yrs)
8.500800E-01
Normal-vs-Age(81-100Yrs)
6.081000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.457170E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.809200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.432400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.388900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.128400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.574400E-01
Normal-vs-Daily Drinker
9.713000E-01
Normal-vs-Weekly Drinker
7.846000E-01
Normal-vs-Occasional Drinker
4.828400E-01
Normal-vs-Social Drinker
5.043800E-01
Non Drinker-vs-Daily Drinker
8.496000E-01
Non Drinker-vs-Weekly Drinker
4.783400E-01
Non Drinker-vs-Occasional Drinker
1.014420E-01
Non Drinker-vs-Social Drinker
1.393170E-01
Daily Drinker-vs-Weekly Drinker
6.303200E-01
Daily Drinker-vs-Occasional Drinker
1.451000E-01
Daily Drinker-vs-Social Drinker
1.791580E-01
Weekly Drinker-vs-Occasional Drinker
4.193600E-01
Weekly Drinker-vs-Social Drinker
3.596400E-01
Occasional Drinker-vs-Social Drinker
7.730200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.002400E-01
Normal-vs-Grade 2
1.057040E-01
Normal-vs-Grade 3
1.433770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.760200E-01
Grade 1-vs-Grade 3
6.396600E-01
Grade 1-vs-Grade 4
4.002400E-01
Grade 2-vs-Grade 3
9.158000E-01
Grade 2-vs-Grade 4
1.057040E-01
Grade 3-vs-Grade 4
1.433770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.367400E-01
Normal-vs-NonDiabetic
6.457000E-01
Diabetic-vs-NonDiabetic
4.386000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.703400E-01
Normal-vs-NoPancreatitis
6.804600E-01
Pancreatitis-vs-NoPancreatitis
9.766600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.875600E-01
Normal-vs-N1
6.231400E-01
N0-vs-N1
4.972000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.570600E-01
Normal-vs-TP53-NonMutant
5.992400E-01
TP53-Mutant-vs-TP53-NonMutant
7.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
